Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnesium Development Company (MDC) is a clinical-stage medical device company focused on the development of bioresorbable magnesium-based implants for orthopedic and trauma surgery. Based in Warsaw, Indiana, the company utilizes a proprietary high-purity magnesium alloy platform designed to provide the structural integrity of traditional metal hardware while gradually resorbing into the body. This technology aims to eliminate the need for secondary surgeries to remove permanent implants, thereby reducing patient morbidity and healthcare costs. MDC's product pipeline includes interference screws for sports medicine and compression screws for fracture fixation. The company's innovations are rooted in collaborative research from leading academic institutions specializing in metallic biomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnesium Development Company.